COEP
Price
$8.95
Change
+$0.10 (+1.13%)
Updated
Jun 6 closing price
Capitalization
31.1M
PDSB
Price
$1.69
Change
+$0.13 (+8.33%)
Updated
Jun 6 closing price
Capitalization
71.76M
66 days until earnings call
Interact to see
Advertisement

COEP vs PDSB

Header iconCOEP vs PDSB Comparison
Open Charts COEP vs PDSBBanner chart's image
Coeptis Therapeutics Holdings
Price$8.95
Change+$0.10 (+1.13%)
Volume$35.01K
Capitalization31.1M
PDS Biotechnology
Price$1.69
Change+$0.13 (+8.33%)
Volume$914.73K
Capitalization71.76M
COEP vs PDSB Comparison Chart
Loading...
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COEP vs. PDSB commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COEP is a Hold and PDSB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (COEP: $9.06 vs. PDSB: $1.37)
Brand notoriety: COEP and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COEP: 38% vs. PDSB: 128%
Market capitalization -- COEP: $31.1M vs. PDSB: $71.76M
COEP [@Biotechnology] is valued at $31.1M. PDSB’s [@Biotechnology] market capitalization is $71.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COEP’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • COEP’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, PDSB is a better buy in the long-term than COEP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COEP’s TA Score shows that 5 TA indicator(s) are bullish while PDSB’s TA Score has 6 bullish TA indicator(s).

  • COEP’s TA Score: 5 bullish, 5 bearish.
  • PDSB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PDSB is a better buy in the short-term than COEP.

Price Growth

COEP (@Biotechnology) experienced а -7.65% price change this week, while PDSB (@Biotechnology) price change was -13.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

PDSB is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PDSB($71.8M) has a higher market cap than COEP($31.1M). COEP YTD gains are higher at: 64.727 vs. PDSB (-15.951). PDSB has more cash in the bank: 49.8M vs. COEP (1.14M). COEP has less debt than PDSB: COEP (1.78M) vs PDSB (24.7M).
COEPPDSBCOEP / PDSB
Capitalization31.1M71.8M43%
EBITDAN/A-36.65M-
Gain YTD64.727-15.951-406%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash1.14M49.8M2%
Total Debt1.78M24.7M7%
FUNDAMENTALS RATINGS
COEP vs PDSB: Fundamental Ratings
COEP
PDSB
OUTLOOK RATING
1..100
788
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
9596
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3762
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDSB's Valuation (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for COEP (76) in the null industry. This means that PDSB’s stock grew somewhat faster than COEP’s over the last 12 months.

COEP's Profit vs Risk Rating (95) in the null industry is in the same range as PDSB (96) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to PDSB’s over the last 12 months.

PDSB's SMR Rating (99) in the Pharmaceuticals Major industry is in the same range as COEP (100) in the null industry. This means that PDSB’s stock grew similarly to COEP’s over the last 12 months.

COEP's Price Growth Rating (37) in the null industry is in the same range as PDSB (62) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to PDSB’s over the last 12 months.

COEP's P/E Growth Rating (100) in the null industry is in the same range as PDSB (100) in the Pharmaceuticals Major industry. This means that COEP’s stock grew similarly to PDSB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COEPPDSB
RSI
ODDS (%)
Bearish Trend 12 days ago
45%
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
67%
Bearish Trend 12 days ago
89%
Momentum
ODDS (%)
Bearish Trend 12 days ago
56%
Bullish Trend 12 days ago
81%
MACD
ODDS (%)
Bullish Trend 12 days ago
49%
Bullish Trend 12 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
68%
Bearish Trend 12 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
40%
Bullish Trend 12 days ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
61%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
48%
Bearish Trend 12 days ago
88%
Aroon
ODDS (%)
Bullish Trend 13 days ago
22%
Bullish Trend 12 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
COEP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

COEP and

Correlation & Price change

A.I.dvisor indicates that over the last year, COEP has been loosely correlated with TVRD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if COEP jumps, then TVRD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COEP
1D Price
Change %
COEP100%
-1.41%
TVRD - COEP
36%
Loosely correlated
-7.58%
QRON - COEP
36%
Loosely correlated
N/A
APLT - COEP
26%
Poorly correlated
-1.75%
PDSB - COEP
25%
Poorly correlated
-4.20%
ATNM - COEP
24%
Poorly correlated
-3.03%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with KYMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-4.20%
KYMR - PDSB
47%
Loosely correlated
+2.35%
RXRX - PDSB
47%
Loosely correlated
+0.11%
IDYA - PDSB
45%
Loosely correlated
+0.72%
ATOS - PDSB
44%
Loosely correlated
-3.13%
NTLA - PDSB
43%
Loosely correlated
+3.59%
More